高科石化(002778.SZ):子公司中標木瀆新城污水廠二期設施採購及安裝項目
格隆匯 1 月 14日丨高科石化(002778.SZ)公佈,公司近日收到公司控股子公司蘇州中晟環境修復有限公司(“控股子公司”或“中晟環境”)關於木瀆新城污水廠二期設施採購及安裝的中標通知,確定公司控股子公司為木瀆新城污水廠二期設施項目的中標人。
此次公司控股子公司中晟環境中標的“木瀆新城污水廠二期設施採購及安裝”項目,投標報價為1.11億餘元,是控股子公司水處理領域取得的又一成果。若該項目順利中標和實施,有利於進一步開拓和鞏固控股子公司水處理業務市場,將對公司未來經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.